Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-03-15
2011-03-15
Aulakh, Charanjit S (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C435S007200, C435S184000
Reexamination Certificate
active
07906531
ABSTRACT:
Muscarinic Acetylcholine receptor antagonists and methods of using them are provided.
REFERENCES:
patent: 2800478 (1923-07-01), Zirkle et al.
patent: 2800481 (1923-07-01), Zirkle et al.
patent: 3634582 (1972-01-01), Hartley et al.
patent: 5590645 (1997-01-01), Davies et al.
patent: 5780466 (1998-07-01), Emonds-Alt et al.
patent: 5860419 (1999-01-01), Davies et al.
patent: 5873360 (1999-02-01), Davies et al.
patent: 6248752 (2001-06-01), Smith
patent: 6262066 (2001-07-01), Tulshian et al.
patent: 6350758 (2002-02-01), Kozikowski et al.
patent: 6455527 (2002-09-01), Tulshian et al.
patent: 6696462 (2004-02-01), Eickmeier et al.
patent: 6750226 (2004-06-01), Forner et al.
patent: 7232841 (2007-06-01), Busch-Petersen et al.
patent: 7276521 (2007-10-01), Busch-Petersen et al.
patent: 7439255 (2008-10-01), Wan et al.
patent: 7563803 (2009-07-01), Wan et al.
patent: 2005/0020660 (2005-01-01), Guyaux et al.
patent: 2005/0113417 (2005-05-01), Mammen et al.
patent: 2005/0209272 (2005-09-01), Fernandez et al.
patent: 2005/0277676 (2005-12-01), Laine et al.
patent: 2006/0160844 (2006-07-01), Belmonte et al.
patent: 2006/0178395 (2006-08-01), Belmonte et al.
patent: 2006/0178396 (2006-08-01), Belmonte et al.
patent: 2007/0129396 (2007-06-01), Wan et al.
patent: 2007/0135478 (2007-06-01), Palovich
patent: 2007/0149598 (2007-06-01), Busch-Petersen et al.
patent: 2007/0173646 (2007-07-01), Laine et al.
patent: 2007/0179180 (2007-08-01), Busch-Petersen et al.
patent: 2007/0179184 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185088 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185090 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185148 (2007-08-01), Busch-Petersen et al.
patent: 2007/0185155 (2007-08-01), Laine et al.
patent: 2007/0232599 (2007-10-01), Palovich et al.
patent: 0069715 (1982-06-01), None
patent: 2064336 (1981-06-01), None
patent: 2129691 (1984-05-01), None
patent: 2169265 (1986-07-01), None
patent: 2178965 (1987-02-01), None
patent: 2242134 (1991-09-01), None
patent: 87/05213 (1987-09-01), None
patent: 2004/012684 (2004-02-01), None
patent: 2006/050239 (2006-05-01), None
patent: 2006/055503 (2006-05-01), None
patent: 2006/055553 (2006-05-01), None
patent: 2006/062883 (2006-06-01), None
patent: 2006/062931 (2006-06-01), None
patent: 2006/065755 (2006-06-01), None
patent: 2006/065788 (2006-06-01), None
patent: 2007/016639 (2007-02-01), None
patent: 2007/016650 (2007-02-01), None
patent: 2007/018508 (2007-02-01), None
patent: 2007/018514 (2007-02-01), None
patent: 2007/022351 (2007-02-01), None
Brown,History and Basic Properties, Humana Press, USA pp. 7-9 (1989).
Caulfield,Pharmac. Ther., vol. 58 pp. 319-379 (1993).
Costello, et al.,American Journal of Physiology, vol. 276 (5) pp. L709-L714 (1999).
Fryer and Jacoby,Am J Respir Crit Care Med, vol. 158 (5, pt 3) pp. 154-160 (1998).
Fryer et al.,Life Sci, vol. 64 (6-7) pp. 449-455 (1999).
Hedge, et al.,Life Sciences, vol. 64 (6/7) pp. 419-428 (1999).
Ikeda, et al.,Naunyn-Schmiedeberg's Arch Pharmacol., vol. 366, pp. 97-103, (2002).
Minette, et al.,Journal of Applied Physiology, vol. 67(6) pp. 2461-2465 (1989).
Oprins, et al.,Annals of the New York Academy of Sciences, vol. 915 pp. 102-106 (2000).
Pauwels et al.,Am. J. Respir. Crit. Care Med., vol. 163 pp. 1256-1276 (2001).
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984) Abstract only.
Sarau,Mol. Pharmacol., vol. 56 (3) p. 657-63 (1999).
Van Rossum, et al.,Arch. Int. Pharmacodyn., vol. 143 p. 299 (1963) Best Available Copy.
Wu, et al.,Zhongguo Yaowu Huazue Zazhi, vol. 3 (1) pp. 23-26 (1993)Abstract only.
Zirkle, et al.,J Med Chem, vol. 27 pp. 1269-1279 (1962).
Zirkle, et al.,J Med Chem, vol. 27 pp. 1279-1285 (1962).
Zirkle, et al.,J Med Chem, vol. 5 pp. 341-356 (1962).
Zhang, et al.,J Med Chem, vol. 44 pp. 3937-3945 (2001).
Ran, et al.,Yaoxue Xuebao, vol. 19 (5) pp. 361-366 (1984), with translation.
Wu, et al.,Zhongguo Yaowu Huaxue Zazhi, vol. 3(1) pp. 23-26 (1993), with translation.
Yu, et al.,Yaoxue Xuebao, vol. 18(10) pp. 766-774 (1983), with translation.
Zhang, et al.,Yaoxue Xuebao, vol. 20(10) pp. 752-758 (1985), with translation.
Laine, et al. U.S. Appl. No. 10/585,830, filed Jul. 12, 2006.
Budzik, et al. U.S. Appl. No. 10/598,743, filed Sep. 11, 2006.
Jin, et al. U.S. Appl. No. 10/598,750, filed Sep. 11, 2006.
Laine, et al. U.S. Appl. No. 10/599,717, filed Oct. 6, 2006.
Cooper, et al. U.S. Appl. No. 11/570,981, filed Dec. 20, 2006.
Busch-Petersen, et al. U.S. Appl. No. 11/573,097, filed Feb. 2, 2007.
Busch-Petersen, et al. U.S. Appl. No. 11/573,099, filed Feb. 2, 2007.
Busch-Petersen, et al. U.S. Appl. No. 11/766,318, Jun. 21, 2007.
Busch-Petersen, et al. U.S. Appl. No. 11/766,371, filed Jun. 21, 2007.
Laine, et al. U.S. Appl. No. 11/774,867, May 3, 2007.
Baraniuk, J. Current Allergy and Asthma Reports, 1:207-217 (2001).
Van Koppen et al., Pulmonary Pharmacology 2:131-136 (1989).
Laine Dramane I.
Palovich Michael R.
Wan Zehong
Yan Hongxing
Aulakh Charanjit S
Dinner Dara L.
Furman Theodore R.
Glaxo Group Limited
LandOfFree
M3 muscarinic acetylcholine receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with M3 muscarinic acetylcholine receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and M3 muscarinic acetylcholine receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2649828